Finance

Lists
N790:FRA
LIR Life Sciences Corp
0,13 €
-0,76%
(-0,0010) 1D
15-окт., 09:55:01 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for N790...
Open
0,13 €
High
0,13 €
Low
0,13 €
Mkt. cap
5,73 млн
Avg. vol.
1,27 миң
Volume
0,00
52-wk high
1,58 €
52-wk low
0,08 €
Open
0,13 €
High
0,13 €
Low
0,13 €
Mkt. cap
5,73 млн
Avg. vol.
1,27 миң
Volume
0,00
52-wk high
1,58 €
52-wk low
0,08 €
News stories
From web sources and news partners
About LIR Life Sciences Corp
CEO-
Employees-
Founded2018
HeadquartersВанкувер, Бритиш Колумбия, Канада
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025-ж. окт.
2026-ж. янв.
2026-ж. апр.
2026-ж. июл.
Revenue
-
-
-
-
Cost of goods sold
-
-
6,67 миң
5,00 миң
Cost of revenue
-
-
6,67 миң
5,00 миң
Research and development expenses
-
10,00 миң
52,10 миң
255,17 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61,85 миң
1,13 млн
317,32 миң
323,37 миң
Operating expense
67,88 миң
1,87 млн
1,23 млн
981,44 миң
Total operating expenses
67,88 миң
1,87 млн
1,24 млн
986,44 миң
Operating income
-67,88 миң
-1,87 млн
-1,24 млн
-986,44 миң
Other non operating income
-6,52 миң
-343,44 миң
-57,71 миң
-3,70 миң
EBT including unusual items
-64,24 миң
-2,16 млн
-1,40 млн
-989,04 миң
EBT excluding unusual items
-196,00 миң
-2,21 млн
-1,30 млн
-989,04 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-64,24 миң
-2,16 млн
-1,40 млн
-989,04 миң
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
142,00
-
-
20,00
Interest expense
-
-
-
-
Net interest expenses
10,69 миң
-
-
20,00
Depreciation and amortization charges
-
-
1,28 миң
-
EBITDA
-64,40 миң
-1,87 млн
-1,24 млн
-985,20 миң
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору